Opinion
Video
Ronald D. Alvarez, MD, MBA, provides closing commentary on the current ovarian cancer treatment landscape and the promising outlook over the next 20 years.
AI Outperforms Traditional Methods in Predicting Ovarian Cancer Surgery Outcomes
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
Understanding gMG: Autoantibodies and Life-Altering Muscle Weakness
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease
Kent Hospital MPN Initiative Focuses on Supportive Care